NSB
NEUROSCIEN FPO [NSB]
Healthcare · ASX Small Cap
$0.1000 -4.8%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +9First seen: 2026-02-25
Score Breakdown
Technical52
Catalyst49
Sentiment50
Fundamental70
Momentum76
Risk Gate43
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Near support level (potential bounce)
- Volatility contracting (breakout setup)
- Strong cash runway (18 quarters)
- 4C filed 2026-01-29
- Very high P/S ratio (102.4x)
- Strong revenue growth (+129%)
- Small-cap ($20-100M)
- Strong 12-1 momentum (+170%)
- Strong revenue momentum (+129%)
- Altman Z-Score in grey zone (1.90)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Negative 5-day momentum (-9.1%)
- Below 200-day MA (long-term downtrend)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Half Yearly Report and Accounts
NONE Company Presentation
NONE Successful Clinical Results Achieved under Special Access
LOW Quarterly Activities/Appendix 4C Cash Flow Report
NEGATIVE Trading Halt
Recent ASX Announcements
| 2026-02-25 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-15 | Company Presentation |
| 2026-01-29 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
| 2026-01-12 | Successful Clinical Results Achieved under Special Access PRICE SENSITIVE |
| 2026-01-08 | Trading Halt PRICE SENSITIVE |
Key Metrics
$34.9M
Market Cap
141K
Avg Volume
1.5x
Vol Ratio
$0.03 — $0.26
52-Week Range
N/A
Short Interest
18 qtrs
Cash Runway
-29.6%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 73% |
| L | Leader vs Laggard | laggard | RS: -1 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #19 of 119 · Sector avg: 51
View all Healthcare signals →